Volrustomig
D798MC00002
Phase 2 mab active
Quick answer
Volrustomig for Sub-study 1 Cervical Cancer (Volrustomig Monotherapy) is a Phase 2 program (mab) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)
- Phase
- Phase 2
- Modality
- mab
- Status
- active